226 related articles for article (PubMed ID: 7863823)
21. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S
Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
[TBL] [Abstract][Full Text] [Related]
22. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
[TBL] [Abstract][Full Text] [Related]
23. Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients.
Hamano T; Oseto S; Fujii N; Ito T; Katayama M; Horio M; Imai E; Hori M
Bone; 2005 May; 36(5):909-16. PubMed ID: 15794928
[TBL] [Abstract][Full Text] [Related]
24. The interaction of PTH and dietary phosphorus and calcium on serum calcitriol levels in the rat with experimental renal failure.
Martin-Malo A; Rodriguez M; Martinez ME; Torres A; Felsenfeld AJ
Nephrol Dial Transplant; 1996 Aug; 11(8):1553-8. PubMed ID: 8856210
[TBL] [Abstract][Full Text] [Related]
25. Effects of intravenous EDTA treatment on serum parathyroid hormone (1-84) and biochemical markers of bone turnover.
Guldager B; Brixen KT; Jørgensen SJ; Nielsen HK; Mosekilde L; Jelnes R
Dan Med Bull; 1993 Nov; 40(5):627-30. PubMed ID: 8299406
[TBL] [Abstract][Full Text] [Related]
26. The acute effect of growth hormone on GFR is obliterated in chronic renal failure.
Haffner D; Zacharewicz S; Mehls O; Heinrich U; Ritz E
Clin Nephrol; 1989 Dec; 32(6):266-9. PubMed ID: 2612071
[TBL] [Abstract][Full Text] [Related]
27. Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D.
Slovik DM; Rosenthal DI; Doppelt SH; Potts JT; Daly MA; Campbell JA; Neer RM
J Bone Miner Res; 1986 Aug; 1(4):377-81. PubMed ID: 3503551
[TBL] [Abstract][Full Text] [Related]
28. Effects of conjugated estrogen on the calcitriol response to parathyroid hormone in postmenopausal women.
Marcus R; Villa ML; Cheema M; Cheema C; Newhall K; Holloway L
J Clin Endocrinol Metab; 1992 Feb; 74(2):413-8. PubMed ID: 1309837
[TBL] [Abstract][Full Text] [Related]
29. The effect of estrogen deficiency on bone mineral density, renal calcium and phosphorus handling and calcitropic hormones in the rat.
Dick IM; St John A; Heal S; Prince RL
Calcif Tissue Int; 1996 Sep; 59(3):174-8. PubMed ID: 8694894
[TBL] [Abstract][Full Text] [Related]
30. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
Sánchez Fructuoso AI; Maestro ML; Pérez-Flores I; Valero R; Rafael S; Veganzones S; Calvo N; De la Orden V; De la Flor JC; Valga F; Vidaurreta M; Fernández-Pérez C; Barrientos A
Nephrol Dial Transplant; 2012 Nov; 27(11):4227-35. PubMed ID: 23144073
[TBL] [Abstract][Full Text] [Related]
31. Dissociation of bone formation from resorption during 2-week treatment with human parathyroid hormone-related peptide-(1-36) in humans: potential as an anabolic therapy for osteoporosis.
Plotkin H; Gundberg C; Mitnick M; Stewart AF
J Clin Endocrinol Metab; 1998 Aug; 83(8):2786-91. PubMed ID: 9709948
[TBL] [Abstract][Full Text] [Related]
32. High-dose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton.
Cosman F; Nieves J; Herbert J; Shen V; Lindsay R
J Bone Miner Res; 1994 Jul; 9(7):1097-105. PubMed ID: 7942157
[TBL] [Abstract][Full Text] [Related]
33. Response of the parathyroid gland to infusion of human parathyroid hormone-(1-34) [PTH-(1-34)]: demonstration of suppression of endogenous secretion using immunoradiometric intact PTH-(1-84) assay.
Cosman F; Shen V; Herrington B; Lindsay R
J Clin Endocrinol Metab; 1991 Dec; 73(6):1345-51. PubMed ID: 1955517
[TBL] [Abstract][Full Text] [Related]
34. Effects of short-term insulin-like growth factor-I or growth hormone treatment on bone turnover, renal phosphate reabsorption and 1,25 dihydroxyvitamin D3 production in healthy man.
Bianda T; Hussain MA; Glatz Y; Bouillon R; Froesch ER; Schmid C
J Intern Med; 1997 Feb; 241(2):143-50. PubMed ID: 9077371
[TBL] [Abstract][Full Text] [Related]
35. Effects of strontium ranelate administration on calcium metabolism in female patients with postmenopausal osteoporosis and primary hyperparathyroidism.
Carnevale V; Del Fiacco R; Romagnoli E; Fontana A; Cipriani C; Pepe J; Minisola S
Calcif Tissue Int; 2013 Jan; 92(1):15-22. PubMed ID: 23080188
[TBL] [Abstract][Full Text] [Related]
36. Subcutaneous administration of the amino-terminal fragment of human parathyroid hormone-(1-34): kinetics and biochemical response in estrogenized osteoporotic patients.
Lindsay R; Nieves J; Henneman E; Shen V; Cosman F
J Clin Endocrinol Metab; 1993 Dec; 77(6):1535-9. PubMed ID: 8263137
[TBL] [Abstract][Full Text] [Related]
37. Quantitative evaluation of anticalciuretic effects of synthetic parathyroid hormonelike peptides.
Scheinman SJ; Mitnick ME; Stewart AF
J Bone Miner Res; 1990 Jun; 5(6):653-8. PubMed ID: 2166424
[TBL] [Abstract][Full Text] [Related]
38. A 7-day continuous infusion of PTH or PTHrP suppresses bone formation and uncouples bone turnover.
Horwitz MJ; Tedesco MB; Sereika SM; Prebehala L; Gundberg CM; Hollis BW; Bisello A; Garcia-Ocaña A; Carneiro RM; Stewart AF
J Bone Miner Res; 2011 Sep; 26(9):2287-97. PubMed ID: 21544866
[TBL] [Abstract][Full Text] [Related]
39. Effects of short-term insulin-like growth factor-I (IGF-I) or growth hormone (GH) treatment on bone metabolism and on production of 1,25-dihydroxycholecalciferol in GH-deficient adults.
Bianda T; Glatz Y; Bouillon R; Froesch ER; Schmid C
J Clin Endocrinol Metab; 1998 Jan; 83(1):81-7. PubMed ID: 9435420
[TBL] [Abstract][Full Text] [Related]
40. Effects of 1,25-dihydroxyvitamin D3 on calcium and phosphorus homeostasis in sheep fed diets either adequate or restricted in calcium content.
Wilkens MR; Mrochen N; Breves G; Schröder B
Domest Anim Endocrinol; 2010 Apr; 38(3):190-9. PubMed ID: 19962267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
